Funding
← Back to your selection

Sofinnova Partners

Activity from announced rounds

Activity in this selectionJun 30, 2026 · Jun 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$180.1M
2 disclosed · full round size, not this investor’s share

By stage

Seed1
Series A1

By primary sector

Biotech2

By country

France1
Poland1

Rounds

2 in this selection
Bionyra Pharma

Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.

$165MSeries A
Role not disclosed
Ingenix

Builds AI architecture fusing biological data modalities to accelerate pharma and biotech drug development

€13MSeed+
Role not disclosed